Viropro acquires biotech production facility
US-based biopharmaceutical company Viropro has acquired a Cambridge biotech facility in a deal worth $21 million (£13 million).
News
US-based biopharmaceutical company Viropro has acquired a Cambridge biotech facility in a deal worth $21 million (£13 million).
News
Partner content
Accounting and Finance Software
Accounting and Finance Software